No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules
Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024
Nuwellis Marks First Commercial Sale of QUELIMMUNE Therapy to Cincinnati Children's
Nuwellis Announces Reverse Stock Split
10-Q: Quarterly report
Nuwellis Announces Closing of $2.7 Million Public Offering
No Data